Literature DB >> 31964628

Fool's gold? Why blinded trials are not always best.

Rohan Anand1, John Norrie2, Judy M Bradley1, Danny F McAuley1, Mike Clarke3.   

Abstract

Mesh：

Year:  2020        PMID： 31964628     DOI： 10.1136/bmj.l6228

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  The Trials and Tribulations of Selecting Comparison Groups in Randomized Trials of Nonpharmacological Complementary and Integrative Health Interventions.

Authors:  Karen J Sherman
Journal:  J Altern Complement Med       Date:  2020-03-11       Impact factor: 2.579

2.  Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018.

Authors:  Samuel Coenen; Alike W van der Velden; Daniela Cianci; Herman Goossens; Emily Bongard; Benjamin R Saville; Nina Gobat; Muireann de Paor; Margareta Ieven; Theo J Verheij; Christopher C Butler
Journal:  Br J Gen Pract       Date:  2020-06-25       Impact factor: 5.386

3.  Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions.

Authors:  Anne-Sophie Donnet; Syed Shariq Hasan; Peter J Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2022-02-15       Impact factor: 4.409

4.  Protecting blinded trials in electronic hospital systems.

Authors:  Matthew R Sydes; Wai Keong Wong; Ameet Bakhai; Nicola Joffe; Sharon B Love
Journal:  Clin Trials       Date:  2022-01-11       Impact factor: 2.599

5.  Enhancing opportunistic recruitment and retention in primary care trials: lessons learned from a qualitative study embedded in the Cranberry for Urinary Tract Infection (CUTI) feasibility trial.

Authors:  Oghenekome A Gbinigie; Anne-Marie Boylan; Christopher C Butler; Carl J Heneghan; Sarah Tonkin-Crine
Journal:  BMC Prim Care       Date:  2022-07-26

6.  Blinding of study statisticians in clinical trials: a qualitative study in UK clinical trials units.

Authors:  Mais Iflaifel; Christopher Partlett; Jennifer Bell; Andrew Cook; Carrol Gamble; Steven Julious; Edmund Juszczak; Louise Linsell; Alan Montgomery; Kirsty Sprange
Journal:  Trials       Date:  2022-06-27       Impact factor: 2.728

7.  Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk.

Authors:  Gail Hayward; Christopher C Butler; Ly-Mee Yu; Benjamin R Saville; Nicholas Berry; Jienchi Dorward; Oghenekome Gbinigie; Oliver van Hecke; Emma Ogburn; Hannah Swayze; Emily Bongard; Julie Allen; Sharon Tonner; Heather Rutter; Sarah Tonkin-Crine; Aleksandra Borek; David Judge; Jenna Grabey; Simon de Lusignan; Nicholas P B Thomas; Philip H Evans; Monique I Andersson; Martin Llewelyn; Mahendra Patel; Susan Hopkins; F D Richard Hobbs
Journal:  BMJ Open       Date:  2021-06-18       Impact factor: 2.692

Review 8.  Blinding in Clinical Trials: Seeing the Big Picture.

Authors:  Thomas F Monaghan; Christina W Agudelo; Syed N Rahman; Alan J Wein; Jason M Lazar; Karel Everaert; Roger R Dmochowski
Journal:  Medicina (Kaunas)       Date:  2021-06-24       Impact factor: 2.430

Review 9.  Improving the trustworthiness of findings from nutrition evidence syntheses: assessing risk of bias and rating the certainty of evidence.

Authors:  Lukas Schwingshackl; Holger J Schünemann; Joerg J Meerpohl
Journal:  Eur J Nutr       Date:  2020-12-30       Impact factor: 5.614
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.